BF Biosciences Ltd
Shariah compliantAlphaGen's view
Members only- Alpha scoreHow this quarter's business compares, scored 0–100
- Fair valueWhat the stock may be worth, against today's price
- Trend signalWhether the price trend is up, down or stopping
- Sector rankWhere it stands among its sector peers
Latest results
Quarter: Apr–Jun 2026In the Apr–Jun 2026 quarter, BFBIO's sales rose 37% to Rs 2.2bn, from Rs 1.6bn, and profit after tax rose 29% to Rs 166.1mn, from Rs 129.0mn (compared with Apr–Jun 2025).
Earnings per share were Rs 1.89, against Rs 1.45 a year earlier.
At Rs 122.45, BFBIO trades at 20.0 times earnings.
- P/E ratio
- 20.0
- Dividend yield
- 0.0%
- Dividend payout
- 0%
- of earnings
- Return on equity
- 12%
- Net margin
- 7.0%
- trailing twelve months
- Debt to equity
- 0.30
BFBIO quarterly results
Reported figures| Quarter | Sales | Profit after tax | Net margin | EPS | Dividend / share |
|---|---|---|---|---|---|
| Apr–Jun 2026 | Rs 2.2bn | Rs 166.1mn | 7.5% | Rs 1.89 | — |
| Jan–Mar 2026 | Rs 2.1bn | Rs 118.0mn | 5.5% | Rs 1.33 | — |
| Oct–Dec 2025 | Rs 2.7bn | Rs 188.0mn | 7.0% | Rs 2.13 | — |
| Jul–Sep 2025 | Rs 2.4bn | Rs 160.0mn | 6.6% | Rs 1.81 | — |
| Apr–Jun 2025 | Rs 1.6bn | Rs 129.0mn | 7.9% | Rs 1.45 | — |
| Jan–Mar 2025 | Rs 1.5bn | Rs 125.0mn | 8.3% | Rs 1.40 | — |
| Oct–Dec 2024 | Rs 1.3bn | Rs 80.0mn | 6.0% | Rs 0.90 | — |
| Jul–Sep 2024 | Rs 1.4bn | Rs 114.0mn | 8.2% | Rs 1.80 | — |
BFBIO annual results and dividends
Reported figures| Year | Sales | Profit after tax | EPS | Dividend / share |
|---|---|---|---|---|
| Year to Jun 2026 | Rs 9.5bn | Rs 632.1mn | Rs 7.16 | — |
| Year to Jun 2025 | Rs 5.8bn | Rs 447.0mn | Rs 5.52 | — |
| Year to Jun 2024 | Rs 3.7bn | Rs 386.0mn | Rs 6.09 | — |
| Year to Jun 2023 | Rs 1.8bn | Rs 150.0mn | Rs 2.35 | — |
Balance sheet and price
Balance sheet as of Jun 2026- Total assets
- Rs 9.2bn
- Shareholders' equity
- Rs 5.3bn
- Cash & bank
- Rs 261.7mn
- Total debt
- Rs 1.6bn
- Current ratio
- 1.93
- 3-month high
- Rs 148.13
- 3-month low
- Rs 119.97
- 1-month change
- -5.6%
- 3-month change
- -13.5%
Read more about BFBIO
Other pharmaceuticals companies
- ABOTAbbot Laboratories (Pakistan) LtdRs 927.73P/E 11.1
- AGPAGP LtdRs 157.87P/E 12.7
- CPHLCiti Pharma LtdRs 71.86P/E 15.7
- FEROZFerozsons Laboratories LtdRs 325.07P/E 16.4
- GLAXOGlaxoSmithKline Pakistan LtdRs 316.42P/E 10.4
- HALEONHaleon Pakistan LtdRs 680.74P/E 12.7
- HINOONHighnoon Laboratories LtdRs 948.13P/E 12.1
- HPLHoehcst Pakistan LtdRs 3905.85P/E 10.4
- IBLHLIBL HealthCare LtdRs 42.52P/E 19.1
- LIVENLiven Pharma LimitedRs 31.14
- MACTERMacter International LtdRs 259.64P/E 15.3
- OTSUOtsuka Pakistan LtdRs 366.30P/E 14.4
BFBIO: common questions
What is BFBIO's share price?
BF Biosciences Ltd (BFBIO) last closed at Rs 122.45 on the Pakistan Stock Exchange.
Does BFBIO pay a dividend?
BF Biosciences Ltd reported no dividend for the year to Jun 2026.
What were BFBIO's latest results?
In the Apr–Jun 2026 quarter, BFBIO's sales rose 37% to Rs 2.2bn, from Rs 1.6bn, and profit after tax rose 29% to Rs 166.1mn, from Rs 129.0mn (compared with Apr–Jun 2025).
What is BFBIO's P/E ratio?
At Rs 122.45, BFBIO trades at 20.0 times its earnings.
Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.